MedTrace Logo

Step Rate Retraining to Reduce Injury and Disability (STRIDe)

NCT04747223 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-02-10

No results posted yet for this study

Summary

This study will be the first project to evaluate the effectiveness of wearable technology (Garmin Forerunner35) while performing gait retraining in field on military members. The watch will provide real time feedback to the runner on their step rate while performing running sessions outside of the lab. This allows the runner to modify their step rate to meet a recommended step rate provided by the study team member.

Aim 1: To demonstrate the utility of wearable sensors to modify running step rate through real time biofeedback.

Aim 2: To determine whether altering step rate using real time biofeedback reduces lower extremity musculoskeletal injury reoccurrence within 1 year post training.

Conditions

  • Overuse Injury
  • Lower Extremity Problem
  • Stress Injury, Repetitive
  • Patellofemoral Pain Syndrome
  • Shin Splint

Interventions

OTHER

Run Gait Retraining

Running step rate will be retrained by real-time biofeedback via a watch accelerometer. Recent literature showed that performing gait retraining by altering step rate reduces loading rates and joint stress that are associated with lower extremity injuries (Wilson et al 2014, Lenhart et al 2014, Heidersheit et al 2011).

Sponsors & Collaborators

  • Army-Baylor University Doctoral Program in Physical Therapy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-06-01
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04747223 on ClinicalTrials.gov